Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

CHLORHEXIDINE GLUCONAT

Open
SPE2DP-27-T-0431Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

BOX 555627, CAMP PENDLETON, CA, 92055-5627, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstrfq
High

Read the document

Due in 6 days

Every page of every file, in your free workspace.

Read the document

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Due in 6 days

Everything you need to bid on this one

Open the full contract in your free workspace.

  • 1 solicitation documentRead every page
  • Buyer contactEmail and phone
Open the full contract

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
CHLORHEXIDINE GLUCONATE CLEANSING SOLUTI
CHLORHEXADINE GLUCONATE CLEANING SOLUTION
SURGICAL SCRUB CHLORHEXADINE 16OZ.
DISPENSER REFILL BOTTLE 1% / 61%
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO Sign up to see this detail. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
UNIT OF ISSUE (1) CASE 8 BOTTLES PER CASE
STORE AT 20-25 C (68-77 F)
FLAMMABLE, KEEP AWAY FROM FIRE OR FLAME, HEAT, SPARKS AND SOURCES OF
STATIC DISCHARGE.
TOTAL SHELF LIFE IS 24 MONTHS.
.
THERE SHALL BE A MINIMUM OF 321 MONTHS OF REMAINING SHELF LIFE
AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY.
..
LABEL AND MARKINGS SHALL BE IAW MEDICAL MARKING STD NO. 1
Hazard Communication Standard Notice:
Effective June 1, 2015, Federal Standard No. 313-E, Material Safety Data, Transportation Data and Disposal Data for Hazardous Materials Furnished to Government Activities, establishes the requirement for preparation and submission of Safety Data Sheets (SDS) in lieu of Material Safety Data Sheets (MSDS) by suppliers who provide hazardous materials to government activities.
The Occupational Safety and Health Administration (OSHA) has modified its Hazard Communication Standard (HCS) to conform to the United Nations
SPE2DP-27-T-0431
SECTION B
Globally Harmonized System of Classification and Labeling of Chemicals. As a result of this change, GSA revised Federal Standard No. 313-E requiring Safety Data Sheets for classifying chemicals and communicating the applicable information on labels.
In accordance with the revised standard after June 1, 2015:
1. Suppliers will be required to submit, to the contracting officer for review and approval prior to award, safety data sheets consistent with the requirements found at 29 C.F.R. 1910.1200 for hazardous materials delivered to the Government.
2. Suppliers will also be required to submit, to the contracting officer for review and approval prior to award, Hazardous Communication Standard (HCS) labels in accordance with 29 C.F.R. 1910.1200 requirements or current Consumer Product Safety Act (CPSA), Federal Hazardous Substance Act (FHSA) labels when subject to labeling requirements under those statutes. This product labeling is required for hazardous materials delivered to the Government.
3. Finally, suppliers must train their employees on the new safety data sheets, hazardous communication labels, and requirements of 29 C.F.R. 1910.1200.
For more information on SDS, refer to OSHAs website, available at:
https://www.osha.gov/law-regs.html
For information on 29 C.F.R. 1910.1200, refer to the below link:
https://www.osha.gov/dsg/hazcom/index.html
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
SOLVENTUM US LLC 9KEZ3 P/N 7000002738 CARDINAL HEALTH 200, LLC 07TA6 P/N M9200 SOLVENTUM US LLC 9KEZ3 P/N NDC17518-0051-01 CARDINAL HEALTH 200, LLC 07TA6 P/N NDC17518-0510-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7019219737 0001 CS 8.000
NSN/MATERIAL:6505016755990
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
SPE2DP-27-T-0431
SECTION B
PR: 7019219737 PRLI: 0001 CONT’D
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
M97111
COMMANDING OFFICER
MEDLOG CO, 1ST CRR, 1ST MLG
BOX 555627
CAMP PENDLETON CA 92055-5627
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
M97111
SUPPLY OFFICER
BLDG 22111 6TH ST (1ST CRR)
M/F M97111 MEDLOG CO, 1ST CRR
CAMP PENDLETON CA 92055
US
M/F: (TCN) M9711163214854
RDD:
PROJ: 9AL TP 1
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A0A DIST: ADV: 2A FC: CS
Need Ship Date:00/00/0000 Original Required Delivery Date:11/23/2026
SPE2DP-27-T-0431 NSN/Part Number: 6505-01-675-5990 Quantity: 8 CS Purchase Request: 7019219737QTY: 8 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
Federal
Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics
Solicitation # 75N98027R00020
The National Center for Advancing Translational Sciences within the National Institutes of Health has issued a Sources Sought notice for an IDIQ contract focused on reagent generation for bioanalytical method development on biologics therapeutics. The primary objective is to identify qualified sources capable of generating and delivering high-affinity, specific anti-drug antibodies, including neutralizing antibodies and antibodies against carriers or gene-of-interest protein products. These reagents will support the quantification of novel biologic drugs in biological matrices such as plasma, serum, and tissue homogenates. The anticipated scope includes the production of polyclonal and monoclonal antibodies, specificity characterization, and the delivery of purified antibodies at an estimated scale of 10 to 50 mg per reagent. The required performance standards are rigorous, demanding adherence to US FDA current Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice, as well as ICH and ISO regulations. Contractors must maintain a comprehensive Quality Management Plan and an independent Quality Assurance Unit to ensure all products meet strict quality requirements. Additional requirements include the development of standard operating procedures for packaging and shipping, the maintenance of secure facilities with restricted access, and the implementation of contingency plans for catastrophic events. The anticipated period of performance for this effort is ten years. Interested respondents must be registered in the System for Award Management and provide a capability statement under NAICS code 325411 by November 30, 2026.
National Institutes Of Health Nida

POSTED

4 days ago

DEADLINE

in 10 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Get AI-powered intelligence on this solicitation and the ones like it

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS